Northern Care Alliance NHS Foundation Trust

Running trials

• Recruiting

  Efficacy, Safety, and Tolerability of Zeleciment Basivarsen (DYNE-101) in Participants With Myotonic Dystrophy Type 1

  NCT07486934· Phase 3· Dyne Therapeutics· Source

• Active, not recruiting

  To Evaluate the Efficacy of CVN424 in Parkinson's Disease Participants With Motor Complications

  NCT06553027· Phase 3· Cerevance· Source

• Recruiting

  Enabling Genomic Testing in Cancer of Unknown Primary

  NCT06695494· The Christie NHS Foundation Trust· Source

• Active, not recruiting

  A Study to Learn About the Effectiveness of Etrasimod in People With Ulcerative Colitis

  NCT06294925· Pfizer· Source

• Recruiting

  A Study to Learn How Nusinersen (Spinraza) Affects Participants With Spinal Muscular Atrophy (SMA) Who Took it Before or During Pregnancy And About The Health of Their Babies

  NCT05789758· Biogen· Source

• Active, not recruiting

  A Study to Evaluate the Effects of ACI-7104.056 in Patients With Early Stages of Parkinson's Disease

  NCT06015841· Phase 2· AC Immune SA· Source

• Active, not recruiting

  An Observational Study to Assess Change in Disease Activity and Adverse Events of Upadacitinib in Adult Participants With Moderate to Severe Ulcerative Colitis (UC) in Real-World Practice

  NCT05494606· AbbVie· Source

• Recruiting

  Adult SMA Research and Clinical Hub

  NCT06978985· Newcastle-upon-Tyne Hospitals NHS Trust· Source

• Recruiting

  A Study of the Safety and Activity of Sparsentan for the Treatment of Patients With Immunoglobulin A Nephropathy

  NCT04663204· Phase 2· University of Leicester· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Spinal muscular atrophy2 recruiting
• Childhood cancers1 recruiting
• IgA nephropathy1 recruiting
• Myotonic dystrophy1 recruiting

Closed trials

• Completed

  Early Diagnosis of SSc in the General Rheumatology Clinic - Pilot

  NCT06291142· University of Manchester· Source

• Completed

  A Study for the Participants With Metastatic Hormone Sensitive Prostate Cancer (mHSPC) Treated With Androgen Deprivation Therapy (ADT) Plus Apalutamide or Enzalutamide

  NCT05901649· Janssen-Cilag Ltd.· Source

• Terminated

  A Study of TCD601 (Siplizumab) in New Onset Type 1 Diabetes Patients

  NCT06025110· Phase 2· ITB-Med LLC· Source

• Completed

  A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures

  NCT05614063· Phase 3· Xenon Pharmaceuticals Inc.· Source

• Terminated

  Efficacy and Safety of REC-2282 in Patients With Progressive Neurofibromatosis Type 2 (NF2) Mutated Meningiomas

  NCT05130866· Phase 2/3· Recursion Pharmaceuticals Inc.· Source

Conditions

Diseases this institution publishes on or runs trials for.

• Systemic sclerosis (scleroderma)52 works · 1 trial
• Psoriasis50 works · 0 trials
• Ulcerative colitis23 works · 2 trials
• Atopic dermatitis (eczema)20 works · 0 trials
• Psoriatic arthritis17 works · 0 trials
• Alopecia areata9 works · 0 trials
• Dermatomyositis and polymyositis (myositis)6 works · 0 trials
• Graves' disease5 works · 0 trials
• IgA nephropathy5 works · 1 trial